BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6609919)

  • 21. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
    Marton A; Major P
    Microb Drug Resist; 1996; 2(3):361-9. PubMed ID: 9158796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antimicrobial resistance in Streptococcus pneumoniae in Beijing and molecular typing of penicillin-resistant strains].
    Wang H; Chen M; Huebener R
    Zhonghua Yi Xue Za Zhi; 1999 Apr; 79(4):253-6. PubMed ID: 11601050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antibiotic resistance and serotype distribution of Streptococcus pneumoniae strains isolated from patients at Hacettepe University Medical Faculty].
    Yenişehirli G; Sener B
    Mikrobiyol Bul; 2003 Jan; 37(1):1-11. PubMed ID: 12838672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro susceptibility of 90 penicillin-susceptible and -resistant pneumococci to penicillin G, amoxicillin, amoxicillin/clavulanate, cefaclor, cefuroxime, cefpodoxime, cefixime and imipenem.
    Hupková H; Trupl J
    Folia Microbiol (Praha); 1998; 43(1):68-70. PubMed ID: 9569631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-vitro activities of 16 non-beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Verhaegen J; Verbist L
    J Antimicrob Chemother; 1999 Apr; 43(4):563-7. PubMed ID: 10350388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-vitro activity of levofloxacin against Streptococcus pneumoniae with various levels of penicillin resistance.
    Thomson KS; Chartrand SA; Sanders CC; Block SL
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():15-9. PubMed ID: 10404332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical and bacteriological studies of Streptococcus pneumoniae. Yearly changes in isolation frequencies from clinical specimens, serotype distributions and drug susceptibilities, especially those of beta-lactam-resistant strains].
    Oguri T
    Jpn J Antibiot; 1986 Mar; 39(3):783-806. PubMed ID: 3735669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Resistance to antibiotics of Streptococcus pneumoniae strains].
    Janicka G; Mikucka A; Białek M; Gospodarek E; Kania I; Rózycka B; Krawiecka D; Wojak I; Kruszyńska E
    Pol Merkur Lekarski; 1997 Nov; 3(17):231-3. PubMed ID: 9523479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative susceptibilities of ampicillin and chloramphenicol resistant Haemophilus influenzae to fifteen antibiotics.
    Campos J; Garcia-Tornel S
    J Antimicrob Chemother; 1987 Mar; 19(3):297-301. PubMed ID: 3494722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occurrence of pneumococci with resistance or decreased susceptibility to penicillin in southeast Sweden.
    Kihlström E; Normann B
    Scand J Infect Dis; 1995; 27(5):489-94. PubMed ID: 8588140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children and multidrug resistance].
    Bayer M; Aslan G; Emekdaş G; Kuyucu N; Kanik A
    Mikrobiyol Bul; 2008 Apr; 42(2):223-30. PubMed ID: 18697420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic susceptibility patterns and serotypes of antibiotic resistant and/or invasive Streptococcus pneumoniae strains circulating in Italy.
    Marchese A; Tonoli E; Balistreri G; Debbia E; Schito GC
    Microb Drug Resist; 2000; 6(2):163-70. PubMed ID: 10990272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antibiotic resistance in pneumococci].
    Moreillon P; Wenger A
    Schweiz Med Wochenschr; 1996 Feb; 126(7):255-63. PubMed ID: 8720323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bactericidal activity of cefotaxime, desacetylcefotaxime, rifampin, and various combinations tested at cerebrospinal fluid levels against penicillin-resistant Streptococcus pneumoniae.
    Cormican MG; Erwin ME; Jones RN
    Diagn Microbiol Infect Dis; 1995; 22(1-2):119-23. PubMed ID: 7587024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
    Knudsen JD
    Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence of resistant Streptococcus pneumoniae: a problem in pediatrics.
    McCracken GH
    Pediatr Infect Dis J; 1995 May; 14(5):424-8. PubMed ID: 7638032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vitro killing activity of combinations of beta-lactam agents with aminoglycosides against penicillin-resistant pneumococci.
    Schlegel L; Sissia G; Fremaux A; Geslin P
    J Antimicrob Chemother; 1997 Jan; 39(1):95-8. PubMed ID: 9044034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic susceptibility of alpha- and nonhemolytic streptococci from patients and healthy adults to 24 antimicrobial drugs.
    Traub WH; Leonhard B
    Chemotherapy; 1997; 43(2):123-31. PubMed ID: 9084921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative in-vitro activity of quinupristin/dalfopristin (RP 59500) tested against penicillin-and macrolide-resistant pneumococci by the Etest.
    Biedenbach D; Wanger A; Jones RN
    J Antimicrob Chemother; 1996 Sep; 38(3):553-5. PubMed ID: 8889731
    [No Abstract]   [Full Text] [Related]  

  • 40. Antimicrobial activities of beta-lactam antibiotics and gentamicin against penicillin-susceptible and penicillin-resistant pneumococci.
    Gross ME; Giron KP; Septimus JD; Mason EO; Musher DM
    Antimicrob Agents Chemother; 1995 May; 39(5):1166-8. PubMed ID: 7625807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.